IDXG - Interpace Diagnostics Group, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
+0.011 (+1.177%)
As of 3:54PM EDT. Market open.
Stock chart is not supported by your current browser
Previous close0.909
Bid0.905 x 2100
Ask0.908 x 400
Day's range0.901 - 0.930
52-week range0.720 - 3.200
Avg. volume472,782
Market cap25.631M
PE ratio (TTM)N/A
EPS (TTM)-0.777
Earnings date14 Aug 2017 - 18 Aug 2017
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.50
Trade prices are not sourced from all markets
  • LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm
    Zacks28 days ago

    LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm

    The multi-year, comprehensive laboratory deal to help LabCorp (LH) provide high-quality, high-value and standardized laboratory diagnostics for Appalachian Regional Healthcare.

  • Globe Newswire3 months ago

    Interpace Diagnostics to Present at NobleCon14 on January 29

    PARSIPPANY, N.J. , Jan. 25, 2018 (GLOBE NEWSWIRE) -- INTERPACE DIAGNOSTICS GROUP, INC.(NASDAQ:IDXG), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services for improved patient diagnosis and management, today announced that its President & CEO, Jack Stover will present at NobleCon14 - Noble Capital Markets’ Fourteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida - on Monday, January 29, 2018 at 5:00 pm ET. ...

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes